| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO
1 company
Robert Cohen is CEO at ZOMDF. Robert Cohen's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider.
Robert Cohen has 7 Form 4 filings on record from June 2020 to November 2025, all as Director at Zomedica (ZOMDF), 2020–2025.
The 10 reported transactions were 5 option or other derivative awards, 3 option exercises and 2 open-market sales.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $3.0M.
The largest open-market sale was 3,193,750 shares of ZOMDF at an average $0.81 on June 1, 2021, about $2.6M.